Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy.
Alexander O PasternakJelmer VroomNeeltje A KootstraFerdinand Wnm WitMarijn de BruinDavide De FrancescoMargreet BakkerCaroline A SabinAlan WinstonJan M PrinsPeter ReissBen Berkhoutnull nullPublished in: eLife (2021)
This work was supported by ZonMw (09120011910035) and FP7 Health (305522).
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv positive
- human immunodeficiency virus
- hiv aids
- hiv infected patients
- healthcare
- public health
- single cell
- cell therapy
- circulating tumor
- cell free
- mental health
- nucleic acid
- hepatitis c virus
- men who have sex with men
- hiv testing
- health information
- single molecule
- climate change
- bone marrow
- south africa
- mesenchymal stem cells